Ticker

BROSSARD, Quebec, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology based on Artificial Intelligence (AI), is pleased to announce that it will be presenting at the Centurion One Capital 9th Annual Conference in Toronto, Canada March 5th…

DIAGNOS Inc. (OTCMKTS:DGNOF - Get Free Report)'s share price traded up 1.6% during trading on Tuesday. The company traded as high as $0.2189 and last traded at $0.2175. 300,800 shares were traded during trading, an increase of 261% from the average session volume of 83,233 shares. The stock had previously closed at $0.2140. DIAGNOS

BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology based on Artificial Intelligence (AI), and the École de technologie supérieure (ÉTS) today announced a major federal investment exceeding 1 Million $CAD to accelerate…

BROSSARD, Quebec, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), announces the engagement of Investor Brand Network (“IBN”) to provide corporate communication and awareness solutions to the Corporation.

Fathom (NASDAQ: FTHM - Get Free Report) and DIAGNOS (OTCMKTS:DGNOF - Get Free Report) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, profitability, earnings and risk. Earnings and Valuation This table compares Fathom and